Ann: US Commercial Launch of Bronchitol, page-2

Looking good, now it will not be long before we will see how good bronchitol is going to sell.

Additionally, Chiesi has announced data from the Pharmaxis Phase 3 global clinical trial (CF303)  evaluating the efficacy and safety of Bronchitol in adults with CF has been published online in the  Journal of Cystic Fibrosis.  

Pharmaxis CEO, Gary Phillips said; “We expect Bronchitol sales in the US to contribute strongly to  the product’s global sales and profit growth, making the Pharmaxis mannitol respiratory business  cash flow positive from FY 2021.”